New York State Common Retirement Fund
CNCE

New York State Common Retirement Fund’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

New York State Common Retirement Fund’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-267
Closed -$1K – 3591
2021
Q2 		$1K Sell
267
-23,133
-99% -$97.9K ﹤0.01% 3515
2021
Q1 		$117K Buy
23,400
+4,000
+21% +$32.3K ﹤0.01% 3018
2020
Q4 		$245K Hold
19,400
– – ﹤0.01% 2669
2020
Q3 		$191K Hold
19,400
– – ﹤0.01% 2672
2020
Q2 		$193K Hold
19,400
– – ﹤0.01% 2657
2020
Q1 		$171K Buy
19,400
+100
+0.5% +$986 ﹤0.01% 2534
2019
Q4 		$178K Sell
19,300
-4,700
-20% -$33.3K ﹤0.01% 2783
2019
Q3 		$141K Hold
24,000
– – ﹤0.01% 2926
2019
Q2 		$288K Sell
24,000
-1,400
-6% -$15.1K ﹤0.01% 2644
2019
Q1 		$307K Hold
25,400
– – ﹤0.01% 2529
2018
Q4 		$319K Hold
25,400
– – ﹤0.01% 2491
2018
Q3 		$377K Sell
25,400
-17,394
-41% -$274K ﹤0.01% 2551
2018
Q2 		$720K Buy
42,794
+9,910
+30% +$192K ﹤0.01% 2287
2018
Q1 		$753K Buy
32,884
+8,753
+36% +$195K ﹤0.01% 2170
2017
Q4 		$624K Buy
24,131
+7,931
+49% +$160K ﹤0.01% 2266
2017
Q3 		$239K Hold
16,200
– – ﹤0.01% 2693
2017
Q2 		$226K Sell
16,200
-1
-0% -$15 ﹤0.01% 2793
2017
Q1 		$276K Buy
16,201
+1
+0% +$12 ﹤0.01% 2647
2016
Q4 		$167K Hold
16,200
– – ﹤0.01% 2833
2016
Q3 		$164K Hold
16,200
– – ﹤0.01% 2832
2016
Q2 		$182K Hold
16,200
– – ﹤0.01% 2778
2016
Q1 		$221K Hold
16,200
– – ﹤0.01% 2633
2015
Q4 		$307K Hold
16,200
– – ﹤0.01% 2547
2015
Q3 		$304K Buy
16,200
+7,260
+81% +$123K ﹤0.01% 2567
2015
Q2 		$133K Buy
+8,940
New +$136K ﹤0.01% 3045

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

New York State Common Retirement Fund's CNCE Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2021, closing a stake of 267 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in CNCE in Q2 2015 and held it in 25 quarters. The position peaked at $753K in Q1 2018. 61 funds tracked by Wall St. Rank hold CNCE as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 267 Concert Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1K.
  • New York State Common Retirement Fund first reported a position in Concert Pharmaceuticals, Inc. in Q2 2015 and held it in 25 quarters.
  • New York State Common Retirement Fund's Concert Pharmaceuticals, Inc. position peaked at $753K in Q1 2018.
  • 61 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.